OverviewSuggest Edit

BioVersys is a company that develops drugs and compounds. The company focuses on research and development of new drugs and compounds, which switch-off drug resistance within bacterial pathogens and restore the efficacy of approved antibiotics. It offers a preclinical candidate against tuberculosis.
HQBasel, CH


BioVersys is headquartered in
Basel, Switzerland

Location Map

Latest Updates

Employees (est.) (Aug 2020)19(+6%)
Cybersecurity ratingCMore

BioVersys Office Locations

BioVersys has an office in Basel
Basel, CH (HQ)
Hochbergerstrasse 60C
Show all (1)

BioVersys Financials and Metrics

Summary Metrics

Founding Date


BioVersys total Funding

$16.7 m

BioVersys latest funding size

$8.87 m

Time since last funding

9 months ago

BioVersys investors

BioVersys's latest funding round in October 2019 was reported to be $8.9 m. In total, BioVersys has raised $16.7 m
Show all financial metrics

BioVersys Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

BioVersys Online and Social Media Presence

Embed Graph

BioVersys Frequently Asked Questions

  • When was BioVersys founded?

    BioVersys was founded in 2008.

  • How many employees does BioVersys have?

    BioVersys has 19 employees.

  • Who are BioVersys competitors?

    Competitors of BioVersys include AN2 Therapeutics, Amunix Pharmaceuticals and AbbVie.

  • Where is BioVersys headquarters?

    BioVersys headquarters is located at Hochbergerstrasse 60C, Basel.

  • Where are BioVersys offices?

    BioVersys has an office in Basel.

  • How many offices does BioVersys have?

    BioVersys has 1 office.